|
2023 |
2022 |
|||||||
|
Q1 |
Q4 |
Q1 |
||||||
Adjusted EBITDA (in millions) |
$ |
35.1 |
|
$ |
27.8 |
|
$ |
47.2 |
|
Divided by Total Net Sales (in millions) |
|
243.8 |
|
|
223.7 |
|
|
248.3 |
|
Adjusted EBITDA Margin |
|
14.4 |
% |
|
12.5 |
% |
|
19.0 |
% |
*Values in table may not add due to rounding. |
|||||||||
Reconciliation of net cash provided by (used in) operating activities to free cash flow*:
|
2023 |
2022 |
||||||
(amounts in millions) |
Q1 |
Q4 |
Q1 |
|||||
Net cash provided by (used in) operating activities |
$ |
1.8 |
|
$ |
127.6 |
|
(13.7 |
) |
Non-acquisition capital expenditures |
|
(16.4 |
) |
|
(29.8 |
) |
(28.2 |
) |
Free cash flow |
$ |
(14.6 |
) |
$ |
97.8 |
|
(42.0 |
) |
*Values in table may not add due to rounding. Net cash provided by operating activities includes regulatory termination fee net of fees and taxes received in Q4 2022. |
||||||||
Reconciliation of GAAP earnings per diluted share to adjusted earnings per diluted share guidance for the 2023 second quarter:
|
Guidance Q2 2023 |
GAAP earnings per diluted share |
$0.65 to $0.85 |
|
|
|
| Discrete items |
$0.16 |
|
|
|
| Acquisition intangible amortization |
$0.14 |
|
|
|
| Adjusted earnings per diluted share |
$0.95 - $1.15 |
